Drug and Therapeutics Bulletin 1999;37:78-80; doi:10.1136/dtb.1999.371078
Copyright © 1999 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Drugs in the peri-operative period: 3 - Hormonal contraceptives and hormone replacement therapy

Relevant BNF sections: 6.4.1.1, 7.3

Women taking combined hormonal contraceptives or hormone replacement therapy (HRT) have an increased risk of developing venous thromboembolism, compared to non-users. Surgery itself carries a risk of thromboembolism, the incidence of which varies with the nature of the procedure. In this article, the third in our series on drug therapy in the peri-operative period,1,2 we review the thromboembolic effects of oral contraceptives and HRT and consider how these affect management around the time of surgery.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1999 BMJ Publishing Group Ltd.